Overview

Efficacy of Intrathecal Administration of Liposomal Amphotericin B in Cryptococcal Meningitis

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The main purpose of this study is to observe the clinical effect of intrathecal administration of liposomal amphotericin B in Cryptococcal Meningitis without Acquired Immune Deficiency Syndrome (AIDS).
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Hui Bu
Treatments:
Amphotericin B
Liposomal amphotericin B
Criteria
Inclusion Criteria:

- Cryptococcus neoformans are found in CSF

Exclusion Criteria:

- Patients with serious heart, lung, liver and renal insufficiency.

- Patients who took broad-spectrum antibiotics and corticosteroids for a long-term.

- Patients with AIDS or obvious immunodeficiency.

- Patients with long term dialysis or intravenous catheter.

- Patients with other brain organic disease such as purulent meningitis, intracranial
swelling, etc.